Ring 1
Ring 2
Ring 3
Ring 4

Evommune

Financing Rounds

  • Series A
  • Series B
  • Series C
Round Led or Co-led By SymBiosis
Round Led or Co-led By SymBiosis
Round Led or Co-led By SymBiosis

Developer of a tissue-based approach designed to advance insights for inflammatory diseases. Evommune develops transformative medicines to advance insights and accelerate the development of medicines. The company has built a robust pipeline of unique therapies with the potential to help patients with chronic inflammatory diseases.

enterome View Website

Modality

  • Small Molecule

Indications

  • Dermatology
  • Immunology & Inflammation

Development Status

  • Phase 1